We have previously reported that glioma-bearing mice could be cured by peripheral whole cell immunizations using granulocyte macrophage colony-stimulating factor (GM-CSF)-transduced tumour cells in the GL261 mouse glioma model, and that the therapeutic effect was mediated by both CD4+ and CD8+ T cells27,28. This evidence concerns the gene CSF2 and neoplasm.